A detailed history of Tru North Capital Management, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Tru North Capital Management, LLC holds 101 shares of BSX stock, worth $9,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares
101
Previous 41 146.34%
Holding current value
$9,198
Previous $3.16 Million 168.1%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$72.96 - $84.0 $4,377 - $5,040
60 Added 146.34%
101 $8.46 Million
Q1 2024

Jun 17, 2024

BUY
$57.6 - $68.62 $2,361 - $2,813
41 New
41 $2.81 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Tru North Capital Management, LLC Portfolio

Follow Tru North Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tru North Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tru North Capital Management, LLC with notifications on news.